Peptides and related molecules that modulate nerve growth factor activity

Details for Australian Patent Application No. 2008201194 (hide)

Owner Amgen Inc.

Inventors Min, Hosung; Wild Jr., Kenneth D.; Boone, Thomas C.; Sitney, Karen C.; Kimmel, Bruce

Agent Shelston IP

Pub. Number AU-B-2008201194

Parent 2003275137

Filing date 12 March 2008

Wipo publication date 3 April 2008

Acceptance publication date 30 June 2011

International Classifications

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

3 April 2008 Application Open to Public Inspection

  Published as AU-B-2008201194

3 April 2008 Complete Application Filed

30 June 2011 Application Accepted

  Published as AU-B-2008201194

27 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008201195-Power divider/combiner and power dividing/combining method using the same

2008201193-Degradation and detection of TSE infectivity